LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Mar 16, 2023
Discovery & Translation
NONO-targeted small molecules for prostate cancer, innovations in single cell methods and more
BioCentury’s roundup of translational news
Read More
BioCentury
|
May 13, 2020
Product Development
Arvinas unveils first efficacy signal for targeted protein degradation, points to opportunity in resistant cancers
Read More
BioCentury
|
Jul 18, 2019
Financial News
Kronos parlays diverse pipeline into $105M series A
Read More
BioCentury
|
Sep 20, 2018
Emerging Company Profile
Recalcitrant Targets
How Kronos’ small molecule microarrays could help drug the undruggable
Read More
BioCentury
|
May 30, 2018
Distillery Therapeutics
Cancer
Read More
BioCentury
|
Oct 31, 2017
Distillery Therapeutics
Cancer
Read More
BioCentury
|
Aug 1, 2016
Clinical News
Galeterone: Phase III discontinued
Read More
BioCentury
|
Jul 26, 2016
Clinical News
Tokai ending galeterone study
Read More
BioCentury
|
Jul 20, 2015
Clinical News
Galeterone: Phase III started
Read More
BioCentury
|
Apr 13, 2015
Company News
Qiagen N.V, Tokai deal
Read More
Items per page:
10
1 - 10 of 13